Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
06/08/2026 13:01
BRIEF-Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million Aug 06 (Reuters) - Aurinia Pharmaceuticals Q2 product revenue USD 79.412 million.
- Q2 net income USD 37.414 million
- Q2 operating income USD 46.341 million
- Q2 operating expenses USD 36.879 million
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death